Table of Content




1. Executive Summary


2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends and Forecast
3.2: Global Cardiovascular Device Market Trends and Forecast
3.3: Global Cardiovascular Device Market by Type
3.3.1: Cardiac Rhythm Management (CRM)
3.3.2: Interventional Cardiac Devices
3.3.3: Peripheral Vascular Devices
3.3.4: Cardiac Assist Devices
3.3.5: Structural Heart Devices
3.3.6: Cardiovascular Surgery
3.3.7: Electrophysiology
3.3.8: Diagnostic & Monitoring Devices
3.4: Global Cardiovascular Device Market by Device
3.4.1: Pacemaker
3.4.2: Defibrillator
3.4.3: Stent
3.4.4: Cardiac Catheter
3.4.5: Guidewire
3.4.6: Heart Valve
3.4.7: Electrocardiogram (ECG)
3.4.8: Event Monitor
3.4.9: Others


4. Market Trends and Forecast Analysis by Region
4.1: Global Cardiovascular Device Market by Region
4.2: North American Cardiovascular Device Market
4.2.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
4.2.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
4.2.3: The United States Cardiovascular Device Market
4.3: European Cardiovascular Device Market
4.3.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
4.3.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
4.3.3: Cardiovascular Device Market of Germany
4.3.4: The French Cardiovascular Device Market
4.3.5: Cardiovascular Device Market of the United Kingdom
4.3.6: The Italian Cardiovascular Device Market
4.3.7: The Spanish Cardiovascular Device Market
4.4: APAC Cardiovascular Device Market
4.4.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
4.4.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
4.4.3: Japanese Cardiovascular Device Market
4.4.4: The Chinese Cardiovascular Device Market
4.4.5: Indian Cardiovascular Device Market
4.5: ROW Cardiovascular Device Market
4.5.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
4.5.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
4.5.3: Brazilian Cardiovascular Device Market


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis


6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin


7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Cardiovascular Device Market by Type
7.1.2: Growth Opportunities for the Global Cardiovascular Device Market by Device
7.1.3: Growth Opportunities for the Global Cardiovascular Device Market by Region
7.2: Emerging Trends in the Global Cardiovascular Device Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Cardiovascular Device Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiovascular Device Market
7.3.4: Technology Development


8. Company Profiles of Leading Players
8.1: Abbott Laboratories
8.2: Boston Scientific Corporation
8.3: Edwards Lifesciences Corporation
8.4: Medtronic Public Limited Company
8.5: C. R. Bard, Inc.
8.6: Johnson & Johnson
8.7: St. Jude Medical Inc.
8.8: Cook Medical Inc.
8.9: Terumo Corporation
8.10: Cardinal Health Inc.